http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-7409946-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d629f98a51b15993f56f9e04fdea237f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-236
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-234
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-236
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-234
filingDate 1974-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7684883c8fdc1c391ef159d2f1c2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1281d0aeed989232114614f898645b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51123c99c79d83c37d3a0d680cc1c55f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8e0b85c902d0fabe9678f17069aaac9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23acdf4c68c7ee82af251bfb099e1bdd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9472e36e1ab8bfad1f92cf098e4f24f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cbe6a842478df968c06122cbdd6e036
publicationDate 1975-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SE-7409946-L
abstract 1473733 Pseudo trisaccharides SCHERICO Ltd 1 Aug 1974 [6 Aug 1973 19 March 1974 (2)] 33968/74 Heading C2C The invention comprises 1-N substituted derivatives of the 4,5-di-(aminoglycosyl)-1,3- diaminocyclitols gentamicin A, gentamicin B, gentamicin B 1 , gentamicin C 1 , gentamicin C 1a , gentamicin C 2 , gentamicin C 2a , gentamicin C 2b , gentamicin X 2 , sisomicin, vendamicin, tobramycin, Antibiotic G-418, Antibiotic 66-40B, Antibiotic 66-40D, Antibiotic J1-20A, Antibiotic J1-20B, Antibiotic G-52, mutamicin 1, mutamicin 2, mutamicin 4, mutamicin 5 and mutamicin 6, where the substituent is -CH 2 X with X being hydrogen, alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, hydroxyalkyl, aminoalkyl, N-alkylaminoalkyl, aminohydroxyalkyl, N-alkylaminohydroxyalkyl, phenyl, benzyl or tolyl, said aliphatic radicals having up to seven carbon atoms and, if substituted by amino and hydroxy, bearing the substituents on different C atoms and pharmaceutically acceptable acid addition salts thereof. The compounds of the invention may be prepared by treating one of the above named 4,6-di-(aminoglycosyl)-1,3- diaminocyclitols which may have aminoprotecting groups at any position other than position 1, with an aldehyde of formula X<SP>1</SP>-CHO, with X<SP>1</SP> being a group as defined for X above wherein any amino or hydroxy group present may be protected in the presence of a hydride donor and reducing agent and, if required, removing all protecting groups present in the molecule the last process step being followed by isolating the derivative as such or as a pharmaceutically acceptable acid addition salt.
priorityDate 1973-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415749575
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72396
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503618
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12799056
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415749574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11754987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3041261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416226939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426283030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12810388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415863172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409070806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416225931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425330703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415732542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416226608
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15574862
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426612200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3042922
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415824599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426198794

Total number of triples: 60.